Abstract
We investigated the association between herpes zoster (HZ) and dementia, and the effects of antiviral therapy on the risk of dementia. We used the National Health Insurance Service-National Sample Cohort in South Korea to identify individuals that were followed from January 1, 2002, to December 31, 2013. Occurrences of HZ and dementia were identified using the relevant diagnostic codes. Dementia was defined as the presence of diagnostic codes and history of anti-dementia drug prescription. Propensity score matching (1:1) was carried out among HZ patients according to antiviral therapy. A total of 229,594 individuals aged ≥50 years were analyzed. The incidences of the first-diagnosed HZ and dementia were 16.69 and 4.67 per 1000 person-years (PY), respectively. HZ patients had a higher risk of dementia (incidence rate ratio [IRR], 1.94 [95% CI 1.83–2.06]; adjusted hazard ratio [HR], 1.12 [95% CI 1.05–1.19]). Of the 34,505 patients with HZ, 28,873 (84%) had received antiviral treatment. The crude incidence rates of subsequent dementia in the treated and untreated groups were 7.79 and 12.27 per 1000 PY, respectively, resulting in an IRR of 0.64 (95% CI 0.56–0.72) and covariate-adjusted HR of 0.79 (95% CI 0.69–0.90). After propensity score matching, the treated group showed a significantly lower risk of dementia (HR 0.76; 95% CI 0.65–0.90). In this large population-based cohort study, HZ was associated with a higher risk of dementia. The use of antiviral agents in HZ patients was associated with lower risks of dementia.
Similar content being viewed by others
References
Frankish H, Horton R (2017) Prevention and management of dementia: a priority for public health. Lancet 390(10113):2614–2615. https://doi.org/10.1016/s0140-6736(17)31756-7
Prince M, Wimo A, Guerchet M et al (2015) World Alzheimer report 2015: the global impact of dementia. Alzheimer’s Disease International, London
Wortmann M (2012) Dementia: a global health priority—highlights from an ADI and World Health Organization report. Alzheimers Res Ther 4(5):40. https://doi.org/10.1186/alzrt143
Park JH, Eum JH, Bold B, Cheong HK (2013) Burden of disease due to dementia in the elderly population of Korea: present and future. BMC Public Health 13:293. https://doi.org/10.1186/1471-2458-13-293
Elahi FM, Miller BL (2017) A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13(8):457–476. https://doi.org/10.1038/nrneurol.2017.96
Itzhaki RF (2018) Corroboration of a major role for herpes simplex virus type 1 in Alzheimer's disease. Front Aging Neurosci 10:324. https://doi.org/10.3389/fnagi.2018.00324
Tzeng NS, Chung CH, Lin FH, Chiang CP, Yeh CB, Huang SY, Lu RB, Chang HA, Kao YC, Yeh HW, Chiang WS, Chou YC, Tsao CH, Wu YF, Chien WC (2018) Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide population-based cohort study in Taiwan. Neurotherapeutics 15(2):417–429. https://doi.org/10.1007/s13311-018-0611-x
Cohen JI (2013) Clinical practice: herpes zoster. N Engl J Med 369(3):255–263. https://doi.org/10.1056/NEJMcp1302674
Tsai MC, Cheng WL, Sheu JJ, Huang CC, Shia BC, Kao LT, Lin HC (2017) Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE 12(11):e0188490. https://doi.org/10.1371/journal.pone.0188490
Chen VC, Wu SI, Huang KY, Yang YH, Kuo TY, Liang HY, Huang KL, Gossop M (2018) Herpes zoster and dementia: a nationwide population-based cohort study. J Clin Psychiatry. https://doi.org/10.4088/JCP.16m11312
Lee J, Lee JS, Park SH, Shin SA, Kim K (2017) Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC). South Korea Int J Epidemiol 46(2):e15. https://doi.org/10.1093/ije/dyv319
Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, Lee EJ, Ae Shin S (2017) Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 46(3):799–800. https://doi.org/10.1093/ije/dyw253
Jang HD, Park JS, Kim DW, Han K, Shin BJ, Lee JC, Choi SW, Suh SW, Yang JH, Park SY, Cho WJ, Hong JY (2019) Relationship between dementia and ankylosing spondylitis: a nationwide, population-based, retrospective longitudinal cohort study. PLoS ONE 14(1):e0210335. https://doi.org/10.1371/journal.pone.0210335
Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ (2001) Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54(4):387–398
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46(3):399–424. https://doi.org/10.1080/00273171.2011.568786
St Germaine-Smith C, Metcalfe A, Pringsheim T, Roberts JI, Beck CA, Hemmelgarn BR, McChesney J, Quan H, Jette N (2012) Recommendations for optimal ICD codes to study neurologic conditions: a systematic review. Neurology 79(10):1049–1055. https://doi.org/10.1212/WNL.0b013e3182684707
Solomon A, Ngandu T, Soininen H, Hallikainen MM, Kivipelto M, Laatikainen T (2014) Validity of dementia and Alzheimer's disease diagnoses in Finnish national registers. Alzheimers Dement 10(3):303–309. https://doi.org/10.1016/j.jalz.2013.03.004
Jaakkimainen RL, Bronskill SE, Tierney MC, Herrmann N, Green D, Young J, Ivers N, Butt D, Widdifield J, Tu K (2016) Identification of physician-diagnosed alzheimer's disease and related dementias in population-based administrative data: a validation study using family physicians' electronic medical records. J Alzheimers Dis 54(1):337–349. https://doi.org/10.3233/jad-160105
Andreu-Reinon ME, Gavrila D, Chirlaque MD, Colorado-Yohar SM, Amiano P, Ardanaz E, Navarro-Mateu F, Navarro C, Huerta JM (2019) Ascertainment of dementia cases in the Spanish European Prospective Investigation into Cancer and Nutrition-Murcia Cohort. Neuroepidemiology 52(1–2):63–73. https://doi.org/10.1159/000493209
Altman DG, De Stavola BL (1994) Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med 13(4):301–341
Li Q, Ali MA, Cohen JI (2006) Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell 127(2):305–316. https://doi.org/10.1016/j.cell.2006.08.046
Bernstein HG, Keilhoff G, Dobrowolny H, Steiner J (2019) Binding varicella zoster virus: an underestimated facet of insulin-degrading enzyme s implication for Alzheimer s disease pathology? Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-019-00995-1
Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW (2005) Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via toll-like receptor 2. J Virol 79(20):12658–12666. https://doi.org/10.1128/jvi.79.20.12658-12666.2005
Haanpaa M, Dastidar P, Weinberg A, Levin M, Miettinen A, Lapinlampi A, Laippala P, Nurmikko T (1998) CSF and MRI findings in patients with acute herpes zoster. Neurology 51(5):1405–1411. https://doi.org/10.1212/wnl.51.5.1405
Wozniak MA, Frost AL, Itzhaki RF (2009) Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16(2):341–350. https://doi.org/10.3233/jad-2009-0963
Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB (2007) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429(2–3):95–100. https://doi.org/10.1016/j.neulet.2007.09.077
Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, Dupuis G, Frost EH, Fulop T Jr (2015) beta-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology 16(1):85–98. https://doi.org/10.1007/s10522-014-9538-8
Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, Gyorgy B, Breakefield XO, Tanzi RE, Moir RD (2018) Alzheimer's disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99(1):56–63.e53. https://doi.org/10.1016/j.neuron.2018.06.030
Cribbs DH, Azizeh BY, Cotman CW, LaFerla FM (2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. Biochemistry 39(20):5988–5994. https://doi.org/10.1021/bi000029f
Baird NL, Zhu S, Pearce CM, Viejo-Borbolla A (2019) Current in vitro models to study varicella zoster virus latency and reactivation. Viruses. https://doi.org/10.3390/v11020103
Mahalingam R, Gershon A, Gershon M, Cohen JI, Arvin A, Zerboni L, Zhu H, Gray W, Messaoudi I, Traina-Dorge V (2019) Current in vivo models of varicella-zoster virus neurotropism. Viruses. https://doi.org/10.3390/v11060502
Kim MC, Yun SC, Lee HB, Lee PH, Lee SW, Choi SH, Kim YS, Woo JH, Kim SH, Kwon SU (2017) Herpes zoster increases the risk of stroke and myocardial infarction. J Am Coll Cardiol 70(2):295–296. https://doi.org/10.1016/j.jacc.2017.05.015
Pendlebury ST, Rothwell PM (2019) Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol 18(3):248–258. https://doi.org/10.1016/s1474-4422(18)30442-3
Donahue JG, Choo PW, Manson JE, Platt R (1995) The incidence of herpes zoster. Arch Intern Med 155(15):1605–1609
Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H (2005) Incidence of herpes zoster, 1997–2002. Epidemiol Infect 133(2):245–253. https://doi.org/10.1017/s095026880400281x
Bae JB, Kim YJ, Han JW, Kim TH, Park JH, Lee SB, Lee JJ, Jeong HG, Kim JL, Jhoo JH, Yoon JC, Kim KW (2015) Incidence of and risk factors for Alzheimer's disease and mild cognitive impairment in Korean elderly. Dement Geriatr Cogn Disord 39(1–2):105–115. https://doi.org/10.1159/000366555
Khadr L, Harfouche M, Omori R, Schwarzer G, Chemaitelly H, Abu-Raddad LJ (2019) The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions. Clin Infect Dis 68(5):757–772. https://doi.org/10.1093/cid/ciy562
Funding
This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HI15C1763).
Author information
Authors and Affiliations
Contributions
All authors critically revised the manuscript for important intellectual content. SHK, SYK, JHW, YSK, SHC, and SOL contributed to the study conception and design. Acquisition, analysis, and interpretation of data was performed by SCY, SB, WY, and MCK. SB and JSL drafted the manuscript. SCY carried out the statistical analysis. SB and SCY equally contributed to the work. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Corresponding author
Ethics declarations
Conflict of interest
All authors have completed the ICMJE uniform disclosure form at https://www.icmje.org/coi_disclosure.pdf and declare: support from the Ministry of Health and Welfare, Republic of Korea; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
Availability of data and material (data transparency)
Not applicable.
Code availability (software application or custom code)
Not applicable.
Rights and permissions
About this article
Cite this article
Bae, S., Yun, SC., Kim, MC. et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci 271, 987–997 (2021). https://doi.org/10.1007/s00406-020-01157-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-020-01157-4